Interaction of androgen-induced autocrine heparin-binding growth factor with fibroblast growth factor receptor on androgen-dependent Shionogi carcinoma 115 cells
- PMID: 2156616
Interaction of androgen-induced autocrine heparin-binding growth factor with fibroblast growth factor receptor on androgen-dependent Shionogi carcinoma 115 cells
Abstract
Stimulation of a Shionogi carcinoma 115-derived cultured cell line (SC-3) with androgen resulted in secretion of heparin-binding growth factor. In this study, we analyzed cell-surfaced receptors for growth factors. Binding data of growth factors on intact SC-3 cells revealed the presence of low and high affinity receptors for epidermal growth factor (EGF), insulin, and fibroblast growth factor (FGF). The dissociation constant values were 50 pM and 1.0 nM for EGF, 1.2 nM and 30 nM for insulin, and 34 pM and 7.5 nM for FGF. The numbers of maximal binding sites were 300 and 900/cell for EGF, 2,000 and 14,000/cell for insulin, and 13,000 and 810,000/cell for FGF. To examine the association of androgen-induced growth factor with one of these receptors, the conditioned medium prepared from androgen-stimulated SC-3 cells was fractionated through a heparin-Sepharose column. Growth factor activity adsorbed and eluted by 1 M NaCl from the column was comigrated with the activity inhibiting FGF-receptor association. In addition, basic 125I-FGF was cross-linked, using disuccinimidyl suberate, to the receptor with an apparent molecular weight of 130,000, whose labeling was inhibited when basic FGF, acidic FGF, or highly purified androgen-induced growth factor was present in excess. Furthermore, the highly purified growth factor-, basic FGF- or androgen-induced growth of SC-3 cells was significantly and similarly inhibited by anti-basic FGF antibody IgG. These results indicate that androgen-induced FGF-like factor acts as an autocrine growth factor via the FGF receptor in a process of SC-3 cell proliferation.
Similar articles
-
Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.J Cell Physiol. 1993 Feb;154(2):254-61. doi: 10.1002/jcp.1041540207. J Cell Physiol. 1993. PMID: 7678839
-
Roles of transforming growth factor beta in inhibition of androgen-induced growth of Shionogi carcinoma cells in serum-free medium.Cancer Res. 1990 Oct 1;50(19):6179-83. Cancer Res. 1990. PMID: 2169337
-
Proliferation of Shionogi carcinoma 115 cells by glucocorticoid-induced autocrine heparin-binding growth factor(s) in serum-free medium.Cancer Res. 1991 Jun 1;51(11):3006-10. Cancer Res. 1991. PMID: 2032238
-
Androgen-induced growth factor and its receptor: demonstration of the androgen-induced autocrine loop in mouse mammary carcinoma cells.J Steroid Biochem Mol Biol. 1993 Dec;47(1-6):91-8. doi: 10.1016/0960-0760(93)90061-z. J Steroid Biochem Mol Biol. 1993. PMID: 8274446 Review.
-
Hormone-induced modification of EGF receptor proteolysis in the induction of EGF action.J Supramol Struct. 1979;12(4):517-31. doi: 10.1002/jss.400120411. J Supramol Struct. 1979. PMID: 233024 Review.
Cited by
-
Appearance of malignant phenotype with partial loss of hormone dependency in androgen-dependent Shionogi Carcinoma 115 transfected with hst-1 gene.Jpn J Cancer Res. 1991 Nov;82(11):1245-51. doi: 10.1111/j.1349-7006.1991.tb01788.x. Jpn J Cancer Res. 1991. PMID: 1836456 Free PMC article.
-
Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity.Jpn J Cancer Res. 1996 Sep;87(9):963-71. doi: 10.1111/j.1349-7006.1996.tb02127.x. Jpn J Cancer Res. 1996. PMID: 8878460 Free PMC article.
-
Three cell lines showing androgen-dependent, -independent, and -suppressed phenotypes, established from a single tumor of androgen-dependent Shionogi carcinoma 115.In Vitro Cell Dev Biol. 1992 Apr;28A(4):245-54. doi: 10.1007/BF02634240. In Vitro Cell Dev Biol. 1992. PMID: 1374755
-
Insulin-like growth factor expression in breast cancer epithelium and stroma.Breast Cancer Res Treat. 1992;22(1):21-9. doi: 10.1007/BF01833330. Breast Cancer Res Treat. 1992. PMID: 1421420 Review.
-
Molecular biology of breast carcinoma.World J Surg. 1994 Jan-Feb;18(1):12-20. doi: 10.1007/BF00348187. World J Surg. 1994. PMID: 8197767 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical